Refine by
Disease Information Articles & Analysis
66 news found
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...
Insights into this paradigm are expected to link the regulation of pathways to the restoration of immune homeostasis for the treatment of a wide range of diseases, including infectious diseases, autoimmune disorders, allograft rejection and malignancies. ...
WGS and Dante’s subsequent genomic reports are valuable health tools that can provide physicians and individuals with information about personalised dietary choices, predisposition to genetic diseases, genetic carrier information and more. ...
This first-of-its-kind sequencing process, which provides an unparalleled understanding of proteins, will advance drug discovery and diagnostics and bring transformative health and disease insights to the world. Founded by world-renowned scientist, entrepreneur, and National Medal of Technology and Innovation recipient Dr. Jonathan Rothberg, Quantum-Si developed its ...
– AMVUTTRA Demonstrated Halting or Reversal in Neuropathy Impairment with Subcutaneous Administration Once Every Three Months – – Decision Follows Positive Opinion from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) in July 2022 – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 20, 2022-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), ...
Despite affecting over 400 million people around the globe, rare diseases have largely been overlooked by traditional drug discovery methods. This is because traditional model often prioritise disease areas where there is a greater understanding of the basic underlying biology and which, in turn, generally come from the larger patient populations associated with more common diseases. This is part ...
NexImmune is also developing new AIM nanoparticle constructs and modalities for potential clinical evaluation in oncology and in disease areas outside of oncology, including autoimmune disorders and infectious disease. For more information, visit www.neximmune.com. About Zephyr AI Zephyr AI is a high-growth healthcare technology company ...
The financial guidance is subject to risks and uncertainties applicable to all forward-looking statements as described elsewhere in this press release. Company and Webcast Information Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. ...
Century Therapeutics (NASDAQ: IPSC) and Bristol Myers Squibb (NYSE: BMY) announced today a research collaboration and license agreement (the “agreement”) to develop and commercialize up to four induced pluripotent stem cell (“iPSC”) derived, engineered natural killer cell (“iNK”) and / or T cell (“iT”) programs for hematologic malignancies and ...
NEW YORK, December 17, 2021 – Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announces that Brooklyn has been added to the ICE Biotechnology Index (NYSE:ICEBIO) following the ...
Riverain developed the first concurrent read FDA cleared algorithm for the early and efficient detection of lung disease. Riverain’s clinically trusted and proven solutions, ClearRead™ CT and ClearRead Xray, remove vessel and bone structure noise, proven to increase efficiency across all chest studies, while simultaneously increasing nodule detection rates. ...
ByAidoc
"The ability to determine the extent and location of recurrent prostate cancer, in conjunction with other available clinical information, can inform the management plan for men with recurrent disease. Informed decision-making can facilitate personalized patient management. ...
RareDiseaseAdvisor.com fills an information gap for HCPs by providing difficult to find information on rare diseases in one convenient place, enabling physicians and care teams with a comprehensive digital resource that will empower them to improve patient outcomes. The site’s thorough approach to covering rare disease news ...
Importantly, for such an alternating schedule to be clinically acceptable, high sensitivity for high-grade disease is key to ensure patients with a high-grade recurrence, who are at risk of disease progression, are detected promptly and treated. ...
Following that, our COO Warren Flood will do a joint presentation with Ricardo Valladares, CSO at Siolta Therapeutics showcasing how we work together to facilitate their drug development in infant allergic disease. For more information about the collaboration with Siolta Therapeutics, please refer to the earlier news release: ...
ByBio-Me
Operating 239 dialysis clinics in 27 states and Washington D.C, ARA partners with approximately 400 nephrologists to advocate for better care and better outcomes for more than 17,000 patients with end stage renal disease (ESRD). “We are pleased to partner with CloudCath through the clinical evaluation of an innovative technology that can dramatically shift the way patients ...
Axial is advancing a pipeline of product candidates with lead clinical programs that address underlying pathology and resulting symptoms in Autism Spectrum Disorder (ASD) and Parkinson’s Disease (PD). For more information, visit ...
” While telehealth has no doubt helped doctors stay connected to their patients for things like chronic disease management and assessing potential COVID-19 symptoms, sometimes a chat over videoconference just isn’t enough. ...
Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the dosing of the first patient as part of the HPV001 clinical study. ...
The company’s tests can identify the presence and type of infection (viral or bacterial), and the risk of severe disease, including severe COVID-19, to enable physicians to make more informed decisions. ...